Vitamin D3 and K2 Together: Why the Pairing Is Popular and What the Evidence Says

Scroll through any wellness feed this spring and you will meet the same confident sentence, usually over a sunrise photo: “Never take vitamin D without K2.” As of June 2025 the phrase has pushed vitamin D3 and K2 into one of the fastest-growing supplement searches in the United States, driven less by a new trial than by a viral idea: that vitamin D on its own is somehow dangerous, pumping calcium into your arteries unless K2 is there to redirect it.

The pairing has a real biochemical story behind it, which is exactly why it travels so well. Vitamin D does increase how much calcium you absorb from food. Vitamin K does switch on proteins that handle calcium in bone and blood vessels. Put those two facts side by side and the conclusion seems to write itself.

It does not, quite. What follows is the honest version: what each vitamin does, what the trials have and have not shown, who should be careful, and how to read the glowing product reviews with a clear head.

Why vitamin D3 and K2 are suddenly everywhere

Supplement trends usually ride on one of three engines: a new study, a celebrity, or a tidy mechanism that sounds like a secret. The vitamin D3 and K2 wave runs mostly on the third. The claim is short enough for a caption and scientific enough to feel authoritative: D3 pulls calcium in, K2 tells it where to go, and taking one without the other leaves calcium “loose” to harden your arteries.

Timing helped. Vitamin D already sits among the most-used supplements in the United States, so a message that says your current habit is incomplete lands on tens of millions of people at once. Meanwhile large trials published over the past few years cooled expectations for vitamin D alone, which created room for a new storyline: maybe the disappointing results happened because the missing partner was absent.

That storyline is attractive, and it is untested in the way that matters. No large randomized trial has compared D3 plus K2 against D3 alone for heart attacks, strokes, or fractures. What exists is a mix of laboratory biology, observational data on dietary vitamin K intake, and small trials measuring surrogate markers such as artery stiffness or the amount of a protein circulating in its inactive form.

None of that makes the pairing silly. A plausible mechanism is where good science starts. The problem is the gap between “plausible” and “proven,” and the way marketing has quietly filled that gap with certainty. A reader deserves to know which side of the line each claim stands on, and that is what the rest of this piece tries to draw.

What changed recently

Three developments set the stage for the current surge, and all three are reflected in the sources listed at the end of this article.

The first was a run of large, well-designed trials of vitamin D alone. The VITAL trial, which randomized more than 25,000 US adults, reported in 2019 that daily vitamin D3 did not reduce cancer or major cardiovascular events compared with placebo, and a 2022 analysis in the same cohort found no reduction in fractures among generally healthy midlife and older adults who were not selected for low vitamin D. The NIH Office of Dietary Supplements updated its vitamin D fact sheet to reflect these results, describing the evidence for heart disease prevention as not supportive. For many readers, that was the moment vitamin D stopped looking like a cure-all and started looking like a nutrient that matters most when you are actually short of it.

The second change was quieter. The same NIH office expanded its vitamin K fact sheet to summarize research on menaquinones, the family of compounds called K2, and vascular calcification. Its conclusion is measured: observational studies associate higher K2 intake with less coronary calcification, but randomized trial evidence for preventing heart disease is limited and inconsistent.

The third was cultural rather than scientific. Short-form video turned the “D3 needs K2” idea into a slogan, and combination products multiplied to meet the demand. Public health agencies have not changed their advice: the NHS still recommends that most adults in the UK consider vitamin D during the darker months, and neither the NHS nor the NIH recommends routine K2 supplementation for the general population. The guidance did not move; the conversation did.

What does vitamin D3 actually do in the body?

Vitamin D is a fat-soluble vitamin, meaning it dissolves in fat rather than water and can be stored in body tissue for weeks. D3, or cholecalciferol, is the form your skin makes when ultraviolet B light hits it and the form found in oily fish, egg yolks and most supplements. D2, or ergocalciferol, comes from plant and fungal sources. Both are converted first in the liver and then in the kidneys into the active hormone that does the actual work, and D3 appears to raise and sustain blood levels somewhat more efficiently than D2.

The job that is beyond dispute is calcium handling. Active vitamin D increases absorption of calcium and phosphorus from the gut; without enough of it, the body absorbs only a fraction of dietary calcium and starts drawing on bone to keep blood calcium stable. In children that produces rickets, with soft, bowed bones. In adults it produces osteomalacia, a softening of bone that causes aching and muscle weakness, and it contributes to osteoporosis, in which bone becomes porous and fracture-prone.

Vitamin D receptors also sit on immune cells, muscle cells and the lining of blood vessels, which is why researchers spent two decades testing it against infections, autoimmune disease, depression and heart disease. Observational studies kept finding that people with low vitamin D did worse, but when randomized trials gave vitamin D to people who were not deficient, most outcomes did not budge. The lesson many experts now draw is that low vitamin D is often a marker of poor health, time indoors or excess body fat storing the vitamin away, rather than the direct cause of everything it travels with.

What does vitamin K2 do, and how is it different from K1?

Vitamin K is the vitamin your blood needs to clot. The letter comes from the German word Koagulation, and the classic deficiency sign is bleeding. It exists in two natural families. Vitamin K1, phylloquinone, is the dominant form in leafy greens such as kale, spinach and broccoli and accounts for most of the vitamin K in a typical diet. Vitamin K2 is a group of compounds called menaquinones, made by bacteria and found in fermented foods, cheese, egg yolk and meat, with natto, a Japanese fermented soybean dish, as the single richest source.

The two forms share one core function: they act as cofactors for an enzyme that “activates” certain proteins by adding a chemical handle that lets them grip calcium. Clotting factors made in the liver are the best known of these proteins. Two others are the reason K2 became a wellness star. Osteocalcin is produced by bone-building cells and, once activated, helps bind calcium into the bone matrix. Matrix Gla protein, often shortened to MGP, is made in the walls of blood vessels and in cartilage, and in its activated form it inhibits calcium from crystallizing where it should not.

K1 is cleared from the blood within hours and is used mostly by the liver. Longer-chain forms of K2, particularly MK-7, circulate for days and reach tissues beyond the liver more readily, which is the biochemical argument for K2 being the “bone and vessel” vitamin. That difference is real in laboratory measurements. Whether it translates into fewer fractures or cleaner arteries in people is the question the studies have not yet settled.

The calcium traffic cop theory: does K2 steer calcium out of arteries?

The most persuasive version of the D3 and K2 story goes like this. Matrix Gla protein is the body’s natural brake on arterial calcification, but it only works after vitamin K activates it. When vitamin K is short, more MGP circulates in the inactive form, the brake weakens, and calcium that vitamin D helped absorb has an easier time settling into artery walls. Give K2, the theory concludes, and you restore the brake.

Each link in that chain has some support. People with higher levels of inactive MGP in their blood tend to have more vascular calcification and worse cardiovascular outcomes in observational studies. Supplementing with K2 reliably lowers inactive MGP within weeks, which shows the mechanism is at least switched on. Animal studies in which vitamin K is blocked show rapid arterial calcification that can be slowed when vitamin K is restored.

The human outcome data are where the chain thins. The Rotterdam Study, a large Dutch cohort, found that people eating the most dietary K2 had less severe aortic calcification and lower cardiovascular mortality than those eating the least, but that is an association in people who also ate differently in a dozen other ways. Randomized trials have mostly tested surrogate endpoints. One three-year trial in postmenopausal women reported less stiffening of the carotid artery with MK-7 than placebo. Other trials, including studies in people with existing coronary calcification or kidney disease, have failed to slow calcification progression on scans. No trial has shown fewer heart attacks or deaths.

So the traffic cop may exist. We do not yet know whether hiring more of them changes what happens on the road.

Does vitamin D3 increase the need for vitamin K2?

This is the specific claim behind the combination products: not merely that both vitamins matter, but that taking D3 creates a K2 shortfall it then needs to cover. It deserves a precise answer.

Vitamin D does increase production of the vitamin K-dependent proteins osteocalcin and MGP. In cell and animal studies, that raises the amount of these proteins waiting to be activated, which in principle means more vitamin K is needed to activate them. Very high doses of vitamin D in animals produce calcification that vitamin K appears to blunt. From this, some researchers have proposed that the two vitamins are functionally linked and that heavy vitamin D use without adequate vitamin K could tip the balance toward calcification.

In humans the picture is far less dramatic. At the intakes most people actually take, vitamin D supplementation has not been shown to cause arterial calcification, and the large trials that gave vitamin D alone for five years did not report an excess of cardiovascular events. If routine vitamin D were quietly hardening arteries, those trials, with tens of thousands of participants, were positioned to see it. They did not.

The more defensible version is this: vitamin K status matters for calcium handling in its own right, many adults get less dietary vitamin K than national recommendations describe, and someone correcting a vitamin D deficiency has a good reason to also eat vitamin K-rich foods or discuss K status with a clinician. That is a reasonable nutrition point. “D3 without K2 is dangerous” is a marketing point, and the evidence does not carry it.

What the evidence actually says about vitamin D3 and K2

Grading evidence means asking how the finding was produced. Randomized controlled trials, which assign people by chance to a treatment or placebo, are the strongest test of whether something causes an effect. Observational studies track what people already do and can show association but not cause. Mechanistic and expert-opinion evidence explains why something might work without showing that it does. Here is how the main claims sort out.

Claim	Best available evidence	Strength
D3 corrects deficiency and prevents rickets and osteomalacia	Decades of clinical data and randomized trials	Strong
D3 plus calcium reduces fractures in older adults who are deficient or institutionalized	Randomized trials and meta-analyses, mixed in healthy populations	Moderate
D3 alone prevents heart disease or cancer in people with normal levels	Large randomized trials showed no benefit	Strong evidence of no effect
K2 lowers inactive MGP and osteocalcin in blood	Multiple small randomized trials	Strong for the marker, unclear for outcomes
K2 slows arterial calcification	Observational association; randomized trials inconsistent	Weak to moderate
K2 reduces fractures	Mostly Japanese trials with MK-4; results mixed	Weak to moderate
D3 plus K2 beats D3 alone for heart or bone outcomes	No adequately powered randomized trial	Insufficient

Read down the right-hand column and the pattern is clear. The strongest evidence belongs to the least exciting claim: vitamin D deficiency is real, common and treatable. The most exciting claim, that the duo together protects arteries, sits at the bottom with no decisive trial behind it. Both the NIH Office of Dietary Supplements and the NHS describe the heart-related evidence for vitamin K as limited and do not recommend K2 supplements for the general public.

Vitamin D3 K2 benefits: what people claim versus what is shown

Product pages and testimonials list benefits with a confidence the research does not share. It helps to walk through the common ones.

“Stronger bones” is the claim with the firmest footing, but mostly through vitamin D. In adults who are deficient, correcting vitamin D improves bone mineralization and, when paired with adequate calcium, reduces fracture risk in frail older people. For K2, Japanese trials using a different menaquinone, MK-4, reported fewer vertebral fractures in women with osteoporosis, though several were small and later analyses were less impressive. A few trials of MK-7 found slower bone loss at the spine or hip in postmenopausal women; others found none. Bone benefit from K2 is possible, not established.

“Heart health” is where the gap between marketing and evidence is widest, as the previous section shows. Lowering a blood marker is not the same as preventing a heart attack. Many promising surrogate improvements in cardiology have failed to translate into fewer events.

“Better immunity” and “more energy” belong to vitamin D’s observational era. Low vitamin D is associated with more respiratory infections and with fatigue, and people who were genuinely deficient often feel better once corrected. Randomized trials in people who were not deficient have generally failed to show fewer infections or improved mood.

“Better dental health” and “fewer wrinkles” appear on some labels with no human trial support at all.

The honest summary: if you are low in vitamin D, bringing it up is worthwhile and well supported. Everything attributed specifically to adding K2 ranges from promising to speculative, and no claim yet reaches the standard of a large outcome trial.

D3 and K2 side effects: what too much actually looks like

Vitamin D is the member of this pair that can cause harm in excess, and the harm has a name: hypercalcemia, meaning too much calcium in the blood. Because vitamin D is stored in fat, prolonged high intake accumulates. The early signs are nonspecific, which is why cases are often missed for months: nausea, vomiting, constipation, loss of appetite, unusual thirst, frequent urination, muscle weakness and confusion. Left unrecognized, high blood calcium can cause kidney stones, kidney damage and heart rhythm disturbances.

Toxicity almost never comes from sunlight, because the skin regulates its own production, and it does not come from food. It comes from supplements, usually from taking far more than any label recommends, from manufacturing errors, or from stacking several products that each contain vitamin D. The NIH Office of Dietary Supplements sets a tolerable upper intake level for adults and notes that most reported toxicity involves intakes many times higher than it. If you take any vitamin D product, that upper level and your own blood level are conversations for your clinician, not for a comment thread.

Vitamin K2 has a very different safety profile. Because the body does not store large amounts and because excess is excreted, no upper intake level has been set, and trials using K2 for several years have reported few side effects beyond occasional digestive upset. The exception is not toxicity but interference: vitamin K directly opposes warfarin and related blood thinners, which is covered below.

Combination products carry one extra caution. Reviewing the ingredients of everything you take, including multivitamins, fortified foods and bone formulas, is the single most useful step for avoiding accidental vitamin D overlap.

Who should not take D3 and K2?

Supplements are often described as harmless by default. For most healthy adults at ordinary intakes that is close to true, but several groups should not start this combination without a clinician’s explicit go-ahead.

Anyone taking warfarin or another vitamin K antagonist tops the list. These medicines work by blocking vitamin K, and adding K2 can reduce their effect and raise the risk of a clot. The relationship is dose-dependent and individual, which is why it is managed, not forbidden, by the prescribing clinician.

People with conditions that already raise blood calcium or sensitize them to vitamin D need caution with the D3 half. That includes primary hyperparathyroidism, in which overactive glands near the thyroid push calcium up; sarcoidosis, tuberculosis and some lymphomas, in which immune cells convert vitamin D to its active form unchecked; and a history of calcium-containing kidney stones. In these conditions even modest vitamin D can tip calcium into the danger zone.

Chronic kidney disease deserves its own mention. The kidneys activate vitamin D and regulate calcium and phosphorus, and people with reduced kidney function often need specific prescribed forms rather than over-the-counter products. Kidney specialists are also cautious about calcium balance and calcification in this group, which cuts both ways for a product marketed on calcium handling.

Pregnant and breastfeeding women should treat vitamin D as part of prenatal care rather than a separate decision, and K2 has little safety data in pregnancy.

Finally, anyone with liver disease, malabsorption conditions such as celiac disease or prior bariatric surgery, or unexplained symptoms that might be hypercalcemia should get tested and advised rather than self-supplement.

Vitamin K2 and warfarin, rosuvastatin, diltiazem: the interaction questions

Three medicine questions show up again and again in searches about this pairing, and they have quite different answers.

Vitamin K2 and warfarin is a genuine, well-documented interaction. Warfarin thins the blood by blocking the enzyme that recycles vitamin K; adding vitamin K from any source pushes in the opposite direction and can drop the INR, the blood test that tracks how thinned the blood is, below the target range. Clinicians do not usually ask patients on warfarin to avoid vitamin K entirely. They ask for consistency, because swings in intake are what destabilize the dose. Starting, stopping or changing a K2 product without telling the anticoagulation clinic is the real hazard. Newer anticoagulants such as apixaban and rivaroxaban do not work through vitamin K and are not affected in the same way, though the prescribing clinician should still know what you take.

Vitamin D and rosuvastatin have no established pharmacological interaction listed by major drug references. Some observational studies have linked low vitamin D to a higher rate of statin-related muscle aches, and small studies have explored whether correcting deficiency helps, but randomized evidence is thin. Taking vitamin D while on rosuvastatin is generally considered compatible; whether to do so, and why, is a question for the clinician who prescribed the statin.

Vitamin D and diltiazem is a more specific concern. Diltiazem is a calcium channel blocker used for blood pressure and heart rhythm. Drug references flag that vitamin D taken in amounts large enough to raise blood calcium can interfere with how calcium channel blockers work and, in rare cases, contribute to rhythm problems. At ordinary intakes in people with normal calcium this is not expected to be an issue, but it is a reason not to self-escalate vitamin D while on diltiazem or verapamil.

Common myths about vitamin D3 and K2

Viral health claims survive because each contains a grain of truth. Here are the grains, and the chaff around them.

“Vitamin D without K2 calcifies your arteries.” The grain: vitamin D raises calcium absorption and vitamin K activates a protein that resists calcification. The chaff: large five-year trials of vitamin D alone did not increase cardiovascular events, and no trial has shown that adding K2 prevents them. At typical intakes, this fear is not supported.

“K2 is proven to reverse artery plaque.” The grain: K2 lowers inactive MGP in blood, and one trial found less arterial stiffening. The chaff: several trials measuring calcification on scans found no slowing, and none measured plaque regression or fewer heart attacks. “Proven” is simply false.

“More vitamin D is always better.” The grain: deficiency is common and correcting it helps bone. The chaff: once blood levels are adequate, extra vitamin D has shown no added benefit in major trials and carries a real, if uncommon, risk of hypercalcemia.

“You cannot get enough K2 from food.” The grain: Western diets contain more K1 than K2. The chaff: the body converts some K1 to K2 in tissues, and cheese, egg yolks, fermented foods and meat all supply menaquinones. Dietary vitamin K deficiency severe enough to affect clotting is rare in healthy adults.

“If a product has thousands of five-star reviews, it must work.” The grain: reviewers are usually sincere. The chaff: a review measures how someone felt after buying, not whether the vitamin changed an outcome, and vitamins with no acute effect generate exactly the same glowing comments as those that do.

How to read reviews and labels for a D3 plus K2 product

Many of the searches that bring people to this topic are really product searches: a particular brand’s softgel, what buyers say about it, whether one formulation beats another. Editorial neutrality means no brand gets a verdict here, but the questions people ask about branded products can be answered in general terms.

Reviews cluster around three themes. Some buyers report feeling more energetic or sleeping better, which can reflect correction of a true deficiency, the placebo response, or seasonal change; a review cannot tell those apart. Others comment on capsule size, smell or the oil used, which are fair practical points. A third group complains of nausea or headache, symptoms that are nonspecific but, if persistent, deserve a blood test rather than a product swap.

Labels are more informative than reviews if you know what to look for. The form of vitamin K matters: MK-7 is the long-acting menaquinone used in most recent trials, while MK-4 was used in older Japanese bone studies and is cleared quickly. Check whether the vitamin D is D3 or D2. Look for third-party testing seals from independent laboratories, because dietary supplements in the United States are not approved for safety or effectiveness before sale, and testing has repeatedly found products whose actual content differs from the label. Vitamin D in particular has been implicated in accidental overdoses from mislabeled or mis-manufactured products.

Then do the arithmetic across everything you take. A multivitamin, a calcium formula, a fish oil with added D and a stand-alone D3 K2 product can quietly add up. Bring the list, or photos of the labels, to your next appointment.

Should you get your vitamin D or vitamin K levels tested?

Vitamin D is measured with a blood test for 25-hydroxyvitamin D, the storage form that best reflects what your skin and diet have supplied over recent weeks. The test is widely available and well standardized. Whether everyone needs it is debated: major bodies do not recommend screening healthy adults without symptoms or risk factors, partly because the cutoffs for “sufficient” differ between organizations and partly because treating a mildly low number in an otherwise well person has not been shown to change outcomes.

Testing makes clear sense when risk is high or symptoms fit. Risk factors include limited sun exposure, darker skin, which produces less vitamin D for the same sunlight, older age, obesity, malabsorption conditions, kidney or liver disease, and medicines that speed vitamin D breakdown, such as some anticonvulsants and glucocorticoids. Symptoms that may point to deficiency include persistent bone or muscle aching, proximal muscle weakness such as difficulty rising from a chair, and in children, bowing of the legs. A test also matters at the other end: anyone taking vitamin D for a long time, or feeling unwell on it, should have both vitamin D and calcium checked.

Vitamin K status is harder to measure. Standard clotting tests only pick up severe deficiency. Research laboratories measure inactive MGP or inactive osteocalcin as markers of tissue vitamin K status, and these can be strikingly abnormal in people on warfarin or with kidney disease, but they are not routine clinical tests and no agreed treatment thresholds exist. For now, vitamin K status is assessed by diet, medicines and clinical context rather than a number on a lab report.

When to see a doctor about vitamin D3 and K2

Most people reading about this pairing are weighing a supplement choice, not facing an emergency. Still, a few situations call for medical input before you start, and a few red flags mean stopping and seeking care promptly.

Talk to a clinician before taking D3 and K2 if you use warfarin or any anticoagulant; have kidney disease, a history of kidney stones, hyperparathyroidism, sarcoidosis or another granulomatous disease; take diltiazem, verapamil, a thiazide diuretic or digoxin, all of which interact with calcium balance; are pregnant or breastfeeding; have a malabsorption condition or prior weight-loss surgery; or are already taking several products containing vitamin D.

Seek care promptly if, while taking vitamin D in any form, you develop persistent nausea or vomiting, constipation that is new for you, excessive thirst with frequent urination, unusual muscle weakness, confusion or drowsiness, or flank pain that could signal a kidney stone. These can be signs of hypercalcemia and are checked with a simple blood test. Seek urgent care for an irregular or racing heartbeat, fainting, or severe abdominal pain.

If you take warfarin, contact your anticoagulation clinic the same day if you notice unusual bruising, bleeding gums, blood in urine or stool, or a nosebleed that will not stop, and tell them about any new supplement, because both too much and too little anticoagulation are dangerous.

Finally, never stop or change a prescribed medicine on the strength of a supplement claim. If you suspect your statin, blood pressure medicine or blood thinner is interacting with a vitamin, the prescriber is the person to decide what, if anything, should change.

Frequently asked questions

Who should not take D3 and K2?

People on warfarin, those with hyperparathyroidism, sarcoidosis, kidney disease or a history of calcium kidney stones, and anyone with unexplained high blood calcium should not start this combination without their clinician’s approval. Pregnant women should fold vitamin D into prenatal care, and K2 has little pregnancy safety data. Everyone else should still check for vitamin D overlap across their other supplements.

What are the main vitamin D3 K2 benefits that are actually proven?

The proven benefit belongs to vitamin D3: correcting deficiency restores bone mineralization and, with adequate calcium, lowers fracture risk in frail older adults. Vitamin K2 reliably lowers blood markers of inactive calcium-binding proteins, but improvements in fractures or artery health in trials have been inconsistent. No trial has shown the pair outperforms D3 alone on any hard health outcome.

Can I safely take vitamin D with rosuvastatin?

Major drug references list no established interaction between vitamin D and rosuvastatin, and the two are commonly taken together. Observational studies link low vitamin D to more statin muscle aches, but randomized evidence that correcting it helps is limited. Whether to add vitamin D while on a statin is a decision for the prescribing clinician, ideally guided by a blood level.

Can vitamin D be taken with diltiazem?

Usually yes at ordinary intakes, but with a caveat. Diltiazem is a calcium channel blocker, and vitamin D taken in amounts large enough to raise blood calcium can blunt its effect and, rarely, contribute to rhythm problems. People on diltiazem or verapamil should not increase vitamin D on their own and should ask their prescriber about periodic calcium monitoring.

What is the difference between vitamin K2 and warfarin's effect on clotting?

They pull in opposite directions. Warfarin blocks the enzyme that recycles vitamin K, which reduces active clotting factors and thins the blood. Vitamin K2 supplies the vitamin warfarin is trying to suppress, so adding it can lower the INR and raise clot risk. Anticoagulation clinics generally ask for a steady vitamin K intake rather than complete avoidance.

Does vitamin D3 need K2 to work?

No. Vitamin D3 corrects deficiency and supports calcium absorption whether or not K2 is present, and the large trials showing its bone benefits used vitamin D without added K2. The idea that D3 is incomplete without K2 rests on laboratory biology and animal studies, not on human outcome trials. Adequate vitamin K from food is still sensible for calcium handling in its own right.

What are the common D3 and K2 side effects?

Vitamin K2 is well tolerated, with occasional digestive upset the main complaint in trials. Side effects from the combination almost always trace to vitamin D in excess: nausea, vomiting, constipation, thirst, frequent urination, weakness and confusion, which signal hypercalcemia. These typically require intakes far above label amounts, often from stacking several vitamin D-containing products or from mislabeled supplements.

Is MK-7 better than MK-4 as a form of K2?

They differ in how long they last rather than in proven effectiveness. MK-7 stays in the blood for days and reaches tissues outside the liver, which is why most recent trials use it. MK-4 clears within hours and was used in older Japanese bone studies. Head-to-head outcome trials are lacking, so neither can be called superior for fractures or heart health.

Can food provide enough vitamin K2 without a supplement?

For most healthy adults, yes, through a mix of sources. Leafy greens supply K1, which the body partly converts to K2 in tissues, while cheese, egg yolks, meat and fermented foods such as natto supply menaquinones directly. Dietary vitamin K deficiency severe enough to affect clotting is rare without malabsorption, liver disease or interfering medicines.

Should I get my vitamin D level tested before taking D3 and K2?

Testing is most useful if you have risk factors or symptoms: little sun exposure, darker skin, older age, obesity, malabsorption, kidney or liver disease, bone or muscle aching, or long-term supplement use. Guidelines do not recommend screening healthy adults without risk factors. A 25-hydroxyvitamin D test, with calcium if you already supplement, gives your clinician a basis for advice.

References

• Vitamin D, NHS
• Vitamin K, NHS
• Vitamin D, MedlinePlus

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.